Funding for this research was provided by:
National Key R&D Program of China (#2018YFC2001800)
Received: 24 February 2021
Accepted: 4 May 2021
First Online: 17 May 2021
: Ethical approval for this study was provided by the Clinical Research Ethics Committee of Peking University First Hospital (Chairperson Prof Guo Xiaohui<b>)</b> on August 4, 2017 (2017, Beijing, China), and registered with Chinese Clinical Trial Registry on September 19, 2017 (chictr. org.cn, ChiCTR-OOC-17012734). Written informed consent was obtained from all participants or their legal representatives.
: Not applicable.
: The authors declare that they have no competing interests.